Active Ingredient: HYDROCHLOROTHIAZIDE; IRBESARTAN
Proprietary Name: IRBESARTAN AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 12.5MG;150MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202414
Product Number: 001
Approval Date: Sep 27, 2012
Applicant Holder Full Name: MACLEODS PHARMACEUTICALS LTD
Marketing Status:
Prescription
Patent and Exclusivity Information
Active Ingredient: HYDROCHLOROTHIAZIDE; IRBESARTAN
Proprietary Name: IRBESARTAN AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 12.5MG;300MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202414
Product Number: 002
Approval Date: Sep 27, 2012
Applicant Holder Full Name: MACLEODS PHARMACEUTICALS LTD
Marketing Status:
Prescription
Patent and Exclusivity Information